Our current results verified a crucial role of mtDNA release and mitophagy dysfunction-mediated innate immune activation in mediating LMNA mutation-induced progeria phenotypes, which may help identifying a novel set of diagnostic markers and therapeutic targets for progeria aging. The gene discussed is LMNA; the disease is progeroid syndrome.